Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

THAKUR, Jeewan,YANG, Dong,FENG, Lili

申请号：

AU2016203145

公开号：

AU2016203145A1

申请日:

2016.05.13

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2016203145A120160602.pdf#####H: dar Inerwoveni NRPorlbl DCC DAR 0147199_I. DOC-13/)5/2016 ABSTRACT The present disclosure relates to crystalline form of (S)-N-((S)-1-cyclohexyl-2-{(S)2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1 -yl}-2-oxo-ethyl)-2-methylaminopropionamide, salts and hydrates thereof. This disclosure also relates to solid oral formulation of (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide, pharmaceutically acceptable salts, solvates (including hydrates) thereof, as well as methods of treatment using the same.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/